Correlation of Non–High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol With Apolipoprotein B During Simvastatin + Fenofibrate Therapy in Patients With Combined Hyperlipidemia (A Subanalysis of the SAFARI Trial)-Reference-Cited by-同舟云学术

Correlation of Non–High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol With Apolipoprotein B During Simvastatin + Fenofibrate Therapy in Patients With Combined Hyperlipidemia (A Subanalysis of the SAFARI Trial)

Published:2009-08 Issue:4 Volume:104 Page:548-553
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Grundy Scott M.,Vega Gloria Lena,Tomassini Joanne E.,Tershakovec Andrew M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report;Circulation,2002

2. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines;Grundy;Circulation,2004

3. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology foundation;Brunzell;Diab Care,2008

4. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy;Grundy;Circulation,2002

5. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management;Grundy;Circulation,2004

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook;Atherosclerosis;2023-10

2. Cardiovascular Risk Assessment in Primary Prevention;Contemporary Cardiology;2022

3. Apolipoprotein B in Primary Prevention: Ready for Time Prime?;Contemporary Cardiology;2022

4. Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science;European Cardiology Review;2020-07-15

5. β-Carotene Oxygenase 1 Activity Modulates Circulating Cholesterol Concentrations in Mice and Humans;The Journal of Nutrition;2020-05-20